SANDEYSO
Live / Allowed — Publication / registration review complete (as of 28 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99944909
- Mark type
- Stylized text
- Filed
- 16 Jul 2026
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Brent A. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, cataplexy in narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss
Owner
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2026 — ASSIGNED TO EXAMINER
- 16 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 16 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Jul 2026 — NEW APPLICATION ENTERED